⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29486936 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL6256623 | 0.69 | — | — | |
| SCHEMBL9633820 | 0.69 | — | — | |
| SCHEMBL11591813 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL5774839 | 0.69 | — | — | |
| SCHEMBL2877864 | 0.69 | — | — | |
| SCHEMBL10898286 | 0.69 | — | — | |
| SCHEMBL2874938 | 0.69 | — | — | |
| SCHEMBL10747846 | 0.67 | — | — | |
| SCHEMBL10747833 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12214061-B2 | Adhesive composition for dental use | KURARAY NORITAKE DENTAL INC. (JP) | 2025-02-04 | — | — | US | disclosed |
| US-20220071852-A1 | ADHESIVE COMPOSITION FOR DENTAL USE | KURARAY NORITAKE DENTAL INC. (JP) | 2022-03-10 | — | — | US | disclosed |
| EP-2211865-A2 | COMBINATION COMPRISING PURINE DERIVATIVES AND OTHER COMPOUNDS AND THE USE THEREOF FOR THE TREATMENT OF INFLAMMATORY AND OBSTRUCTIVE AIRWAY DISEASES | Novartis AG (CH) | 2010-08-04 | — | — | EP | disclosed |
| US-20090238770-A1 | Organic compounds | NOVARTIS AG (CH) | 2009-09-24 | — | — | US | disclosed |
| US-20090181934-A1 | Organic Compounds | NOVARTIS AG | 2009-07-16 | — | — | US | disclosed |
| WO-2009050198-A2 | COMBINATION COMPRISING PURINE DERIVATIVES AND OTHER COMPOUNDS AND THE USE THEREOF FOR THE TREATMENT OF INFLAMMATORY AND OBSTRUCTIVE AIRWAY DISEASES | NOVARTIS AG (CH) | 2009-04-23 | — | — | WO | disclosed |
| EP-1962848-A2 | COMBINATIONS OF INDACATEROL DERIVATIVES AND OTHER AGENTS FOR THE TREATMENT OF AIRWAY DISEASES | Novartis AG (CH) | 2008-09-03 | — | — | EP | disclosed |
| WO-2006128674-A2 | COMBINATIONS OF INDACATEROL DERIVATIVES AND OTHER AGENTS FOR THE TREATMENT OF AIRWAY DISEASES | NOVARTIS AG (CH) | 2006-12-07 | — | — | WO | disclosed |
| EP-1165828-A4 | 50 HUMAN SECRETED PROTEINS | HUMAN GENOME SCIENCES INC (US) | 2002-09-25 | — | — | EP | disclosed |
| EP-1165828-A1 | 50 HUMAN SECRETED PROTEINS | Human Genome Sciences, Inc. (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001019373-A2 | METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-22 | — | — | WO | disclosed |
| WO-2000058496-A1 | 50 HUMAN SECRETED PROTEINS | HUMAN GENOME SCIENCES, INC. (US) | 2000-10-05 | — | — | WO | disclosed |
| EP-0998300-A1 | METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-10 | — | — | EP | disclosed |
| US-5843905-A | Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors | VERTEX PHARMACEUTICALS, INCORPORATED (US) | 1998-12-01 | — | — | US | disclosed |
| US-5843905-A | Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors | VERTEX PHARMACEUTICALS, INCORPORATED (US) | 1998-12-01 | — | — | US | disclosed |
| WO-1998041232-A2 | COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
| EP-0644197-B1 | Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors | VERTEX PHARMA (US) | 1998-09-09 | — | — | EP | disclosed |
| EP-0644197-B1 | Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors | VERTEX PHARMA (US) | 1998-09-09 | — | — | EP | disclosed |
| EP-0644197-A1 | Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors | STERLING WINTHROP INC. (US) | 1995-03-22 | — | — | EP | disclosed |
| EP-0644197-A1 | Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors | STERLING WINTHROP INC. (US) | 1995-03-22 | — | — | EP | disclosed |